Recombinant
RabMAb

Anti-CDKN2A/p16INK4a antibody [EP435Y-129R] (ab81278)

Publishing research using ab81278? Please let us know so that we can cite the reference in this datasheet.

ab81278 has been referenced in 11 publications.

  • Herling CD  et al. Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia. Nat Commun 9:727 (2018). PubMed: 29463802
  • Cretella D  et al. The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells. J Exp Clin Cancer Res 37:72 (2018). PubMed: 29587820
  • Li G  et al. Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461. J Exp Clin Cancer Res 37:78 (2018). PubMed: 29631594
  • Hormaechea-Agulla D  et al. The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness. Mol Cancer 16:146 (2017). PubMed: 28851363
  • Inoue C  et al. SMARCD1 regulates senescence-associated lipid accumulation in hepatocytes. NPJ Aging Mech Dis 3:11 (2017). PubMed: 28868154
  • Prabhavathy D  et al. Re-expression of HPV16 E2 in SiHa (human cervical cancer) cells potentiates NF-?B activation induced by TNF-a concurrently increasing senescence and survival. Biosci Rep 35:N/A (2015). PubMed: 25572145
  • Xu H  et al. Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children. Nat Commun 6:7553 (2015). WB . PubMed: 26104880
  • Blue EK  et al. Gestational diabetes induces alterations in the function of neonatal endothelial colony-forming cells. Pediatr Res 75:266-72 (2014). WB ; Human . PubMed: 24232636
  • Kato H  et al. Hypoxia induces an undifferentiated phenotype of oral keratinocytes in vitro. Cells Tissues Organs 199:393-404 (2014). WB ; Human . PubMed: 25720390
  • Tsuno A  et al. Fasudil inhibits the proliferation and contractility and induces cell cycle arrest and apoptosis of human endometriotic stromal cells: a promising agent for the treatment of endometriosis. J Clin Endocrinol Metab 96:E1944-52 (2011). PubMed: 21917869
  • Kawano Y  et al. Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target. Hum Reprod 26:2486-98 (2011). WB ; Human . PubMed: 21715447

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up